These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19244573)

  • 1. Albuminuria, wherefore art thou?
    Jarad G; Miner JH
    J Am Soc Nephrol; 2009 Mar; 20(3):455-7. PubMed ID: 19244573
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired tubular uptake explains albuminuria in early diabetic nephropathy.
    Russo LM; Sandoval RM; Campos SB; Molitoris BA; Comper WD; Brown D
    J Am Soc Nephrol; 2009 Mar; 20(3):489-94. PubMed ID: 19118149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubuloglomerular feedback in renal hypertrophy.
    Pollock CA; Lawrence JR; Field MJ
    Kidney Int Suppl; 1991 Jun; 32():S106-9. PubMed ID: 1881031
    [No Abstract]   [Full Text] [Related]  

  • 4. Disease-dependent mechanisms of albuminuria.
    Comper WD; Hilliard LM; Nikolic-Paterson DJ; Russo LM
    Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1589-600. PubMed ID: 18579704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of diabetic glomerulopathy: hemodynamic considerations.
    Hostetter TH
    Semin Nephrol; 1990 May; 10(3):219-27. PubMed ID: 2190279
    [No Abstract]   [Full Text] [Related]  

  • 6. Heparan sulphate in the pathogenesis of diabetic nephropathy.
    Kofoed-Enevoldsen A
    Diabetes Metab Rev; 1995 Jul; 11(2):137-60. PubMed ID: 7555565
    [No Abstract]   [Full Text] [Related]  

  • 7. Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy.
    Kobayashi S; Satoh M; Namikoshi T; Haruna Y; Fujimoto S; Arakawa S; Komai N; Tomita N; Sasaki T; Kashihara N
    Clin Exp Nephrol; 2008 Apr; 12(2):119-125. PubMed ID: 18175064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic nephropathy.
    Wardle EN
    Nephron; 1987; 45(3):177-81. PubMed ID: 3553974
    [No Abstract]   [Full Text] [Related]  

  • 9. Extravasation of plasma proteins into the renal interstitium contributes to the pathophysiology of diabetic nephropathy.
    Atkins JL; Pinter GG
    Contrib Nephrol; 1993; 101():139-42. PubMed ID: 8467667
    [No Abstract]   [Full Text] [Related]  

  • 10. Loss of glomerular anionic sites and the development of albuminuria in rats with streptozotocin-induced diabetes.
    Moriya T; Nakazawa K; Itoh N; Shigematsu H; Okada N; Aizawa T; Yamada T; Yajima Y
    Nephron; 1993; 65(3):444-8. PubMed ID: 8289997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice.
    Barutta F; Grimaldi S; Franco I; Bellini S; Gambino R; Pinach S; Corbelli A; Bruno G; Rastaldi MP; Aveta T; Hirsch E; Di Marzo V; Gruden G
    Kidney Int; 2014 Nov; 86(5):979-90. PubMed ID: 24827776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Where does albuminuria come from in diabetic kidney disease?
    Comper WD; Russo LM
    Curr Diab Rep; 2008 Dec; 8(6):477-85. PubMed ID: 18990305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy.
    Cooper ME; Allen TJ; O'Brien RC; Papazoglou D; Clarke BE; Jerums G; Doyle AE
    Diabetes; 1990 Dec; 39(12):1575-9. PubMed ID: 2245881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The patterns of proteinuria in diabetes mellitus. Relevance to pathogenesis and prevention of diabetic nephropathy.
    Viberti G; Keen H
    Diabetes; 1984 Jul; 33(7):686-92. PubMed ID: 6376224
    [No Abstract]   [Full Text] [Related]  

  • 15. Controversies on the prevention of diabetic nephropathy.
    Chiarelli F; Verrotti A; Basciani F; di Ricco L; Sabatino G; Morgese G
    J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():365-9. PubMed ID: 9642666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter to the Editor: "Can early plasma elimination rate be used to quantify renal clearance of macromolecules?".
    Öberg CM; Rippe B
    Am J Physiol Renal Physiol; 2015 Jan; 308(2):F164-5. PubMed ID: 25560050
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased glomerular cell (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: role in the development of diabetic glomerular disease.
    Menini S; Iacobini C; Oddi G; Ricci C; Simonelli P; Fallucca S; Grattarola M; Pugliese F; Pesce C; Pugliese G
    Diabetologia; 2007 Dec; 50(12):2591-9. PubMed ID: 17901943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic glomerulopathy: a dynamic process produced by the diabetic environment.
    Steffes MW; Brown DM; Mauer SM
    Adv Exp Med Biol; 1979; 124():157-66. PubMed ID: 116484
    [No Abstract]   [Full Text] [Related]  

  • 19. How heterogeneous is microalbuminuria in diabetes mellitus? The case for 'benign' and 'malignant' microalbuminuria.
    Stehouwer CD; Yudkin JS; Fioretto P; Nosadini R
    Nephrol Dial Transplant; 1998 Nov; 13(11):2751-4. PubMed ID: 9829474
    [No Abstract]   [Full Text] [Related]  

  • 20. What causes diabetic renal failure?
    Pinter GG; Atkins JL
    Lancet; 1990 Mar; 335(8689):590-1. PubMed ID: 1968584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.